Skip to main content
HR 4006 105th Congress House Crime and Law Enforcement Administrative procedure Administrative remedies Assisted suicide Commerce Department of Justice Drug abuse Drug industry Drug utilization Drugs Euthanasia Evidence (Law) Executive reorganization Federal advisory bodies Government Operations and Politics Health Law Licenses Pain Pharmaceutical research

Lethal Drug Abuse Prevention Act of 1998

Introduced: June 5, 1998 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 18, 1998
Placed on the Union Calendar, Calendar No. 422.
Sep 18, 1998
Committee on Commerce discharged.
Sep 14, 1998
Rules Committee Resolution H. Res. 535 Reported to House. Rule provides for consideration of H.R. 4006 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. It shall be in order to consider as an original bill for the purpose of amendment under the five-minute rule the amendment in the nature of a substitute recommended by the Committee on the Judiciary now printed in the bill. The bill shall be considered under the five-minute rule for a period not to exceed 3 hours. Measure will be considered read. Bill is open to amendments.
Aug 6, 1998
House Committee on Commerce Granted an extension for further consideration ending not later than Sept. 18, 1998.
Aug 6, 1998
Reported (Amended) by the Committee on Judiciary. H. Rept. 105-683, Part I.
Aug 4, 1998
Committee Consideration and Mark-up Session Held.
Aug 4, 1998
Ordered to be Reported (Amended) by Voice Vote.
Jul 22, 1998
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 6 - 5.
Jul 22, 1998
Subcommittee Consideration and Mark-up Session Held.
Jul 14, 1998
Subcommittee Hearings Held.
Jun 19, 1998
Referred to the Subcommittee on the Constitution.
Jun 11, 1998
Referred to the Subcommittee on Health and Environment.
Jun 5, 1998
Referred to House Judiciary
Jun 5, 1998
Referred to House Commerce
Jun 5, 1998
Introduced in House
Jun 5, 1998
Referred to the Committee on the Judiciary, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Plain-English summary Congressional Research Service

Lethal Drug Abuse Prevention Act of 1998 - Amends the Controlled Substances Act (CSA) to require the Attorney General to determine that registration of an applicant to manufacture, distribute, conduct research with, or dispense specified controlled substances or listed chemicals is inconsistent with the public interest if: (1) during the five-year period immediately preceding submission of the application, the applicant's registration was revoked; or (2) the Attorney General determines, based on clear and convincing evidence, that the applicant is applying for the registration with the intention of using such registration to violate CSA provisions.

Authorizes the Attorney General to suspend or revoke a registration upon a finding that the registrant has intentionally dispensed or distributed a controlled substance with a purpose of causing, or assisting in causing, the suicide or euthanasia of any individual.

Directs the Attorney General to establish the Medical Review Board on Pain Relief, which, based on a hearing, shall make findings regarding whether a particular action at issue is an appropriate means to relieve pain that does not constitute a violation of such provision.

What's happening now September 18, 1998

Committee on Commerce discharged.

 Committees of jurisdiction 4
 Cosponsors 3
All 3 Republican 3